C23H32F3N5O5
Neat
515.53
NMW2V4PD8G; Nirmatrelvir metabolite M2; UNII-NMW2V4PD8G; PF-07329266; 2755812-09-8; 3-Azabicyclo(3.1.0)hexane-2-carboxamide, N-((1S)-1-cyano-2-((3S)-2-oxo-3-pyrrolidinyl)ethyl)-3-((2S)-3, 3-dimethyl-1-oxo-2-((2, 2, 2-trifluoroacetyl)amino)butyl)-6-(hydroxymethyl)-6-methyl-, (1R, 2S, 5S, 6S)-; 3-Azabicyclo[3.1.0]hexane-2-carboxamide, N-[(1S)-1-cyano-2-[(3S)-2-oxo-3-pyrrolidinyl]ethyl]-3-[(2S)-3, 3-dimethyl-1-oxo-2-[(2, 2, 2-trifluoroacetyl)amino]butyl]-6-(hydroxymethyl)-6-methyl-, (1R, 2S, 5S, 6S)-; CHEMBL5813863; SCHEMBL24425255; BDBM510130; WO2021250648, Example 82; (1R, 2S, 5S and 6R)-N-{(1 S)-1-Cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl}-6- (hydroxymethyl)-6-methyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide (82)
(1R, 2S, 5S, 6S)-N-[(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl]-3-[(2S)-3, 3-dimethyl-2-[(2, 2 and 2-trifluoroacetyl)amino]butanoyl]-6-(hydroxymethyl)-6-methyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
InChI=1S/C23H32F3N5O5/c1-21(2,3)16(30-20(36)23(24,25)26)19(35)31-9-13-14(22(13,4)10-32)15(31)18(34)29-12(8-27)7-11-5-6-28-17(11)33/h11-16,32H,5-7,9-10H2,1-4H3,(H,28,33)(H,29,34)(H,30,36)/t11-,12-,13-,14-,15-,16+,22-/m0/s1